Novavax Seeks FDA Emergency Use Nod For Its COVID-19 Vaccine Booster
Novavax Inc (NASDAQ:NVAX) has submitted an application to the FDA for Emergency Use Authorization (EUA) for its protein-based COVID-19 vaccine as…
Clene Shares Fall Despite Multiple Sclerosis Candidate Showing Neurological Improvements
Clene Inc (NASDAQ:CLNN) has announced topline results from the Phase 2 VISIONARY-MS trial of CNM-Au, an investigational gold nanocrystal suspension, in…
Raymond James Is Bearish On This Inflammatory Bowel Disease Player On Upcoming ‘Pipeline Reset’
Raymond James downgraded Landos Biopharma Inc (NASDAQ:LABP) to Market Perform from Outperform following 2Q22 earnings and the first look at NX-13…
Competitor Recall Continues To Show Opportunities For ResMed
ResMed Inc (NYSE:RMD) posted Q4 sales of $914.7 million, +4% Y/Y (+8% on a constant currency basis), beating the consensus…
Catalent-Repligen Merger ‘Seems Unlikely,’ This Analyst Says
Yesterday, Catalent Inc (NYSE:CTLT) announced to acquire Metrics Contract Services for $475 million. Keybanc notes that the deal strengthens CTLT’s oral delivery…
Senate Finance Committee Expands Amgen’s Tax Probe: Report
Senator Ron Wyden sent a letter to Amgen Inc (NASDAQ: AMGN) asking what methods the company has used to pay an average effective tax rate of around 12% over the past four years.
FDA Approves Expanded Use Of Roche’s Influenza Treatment
The FDA has approved the expanded use of Roche Holding AG’s (OTC:RHHBY) Xofluza (baloxavir marboxil). The medicine has been approved to treat…
4D Molecular Shares Fall After Filing For Fabry Disease Trial Amendment
4D Molecular Therapeutics Inc (NASDAQ:FDMT) said that in June, the company filed a protocol amendment with the FDA for the ongoing…
Rapid Micro Rejects Takeover Deal, Adopts Poison Pill To Thwart Investor
Rapid Micro Biosystems Inc (NASDAQ: RPID) has initiated a review of strategic alternatives and has retained Morgan Stanley & Co. LLC as…
Daiichi-AstraZeneca’s Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
The FDA has approved Daiichi Sankyo (OTC:DSNKY) and AstraZeneca plc’s (NASDAQ:AZN) Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic non-small cell lung cancer (NSCLC)…